Lepu Biopharma Co., Ltd. (02157) submitted a monthly return for equity issuers, covering the period ended 30 November 2025. According to the announcement, the authorized and issued share capital remained unchanged from the preceding month.

The total authorized share capital stood at RMB 1,804,439,838, divided into 1,804,439,838 ordinary shares of RMB 1 par value each. At the close of November 2025, the issued number of ordinary H shares was 1,804,439,838 with zero treasury shares. No warrants, convertibles, or share options were issued or exercised during the period.

The confirmation provided in the announcement indicated compliance with relevant regulations and completion of all necessary procedural requirements. The document was submitted by Joint Company Secretary, Ms. Li Yunyi.